EDITORIAL
Published on 05 Dec 2012
The key role of ubiquitination and sumoylation in signaling and cancer: a research topic
doi 10.3389/fonc.2012.00187
- 6,778 views
- 10 citations
- Frontiers in Oncology
- Molecular and Cellular Oncology
- Research Topics
- The key role of ubiquitination and sumoylation in signaling and cancer
The key role of ubiquitination and sumoylation in signaling and cancer
26k
Total downloads
126k
Total views and downloads
Articles
REVIEW
Published on 12 Apr 2012
The Roles of VHL-Dependent Ubiquitination in Signaling and Cancer
doi 10.3389/fonc.2012.00035
- 8,688 views
- 34 citations
REVIEW
Published on 09 Apr 2012
CRL Ubiquitin Ligases and DNA Damage Response
doi 10.3389/fonc.2012.00029
- 6,081 views
- 32 citations
REVIEW
Published on 12 Mar 2012
Histone Ubiquitination and Deubiquitination in Transcription, DNA Damage Response, and Cancer
doi 10.3389/fonc.2012.00026
- 52,382 views
- 259 citations
REVIEW
Published on 06 Mar 2012
Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease
doi 10.3389/fonc.2012.00021
- 8,468 views
- 62 citations
REVIEW
Published on 20 Feb 2012
Regulation of Ubiquitination-Mediated Protein Degradation by Survival Kinases in Cancer
doi 10.3389/fonc.2012.00015
- 14,898 views
- 51 citations
REVIEW
Published on 03 Feb 2012
Role of Elongin BC-containing ubiquitin ligases
doi 10.3389/fonc.2012.00010
- 13,570 views
- 67 citations
REVIEW
Published on 31 Jan 2012
K63-Linked Ubiquitination in Kinase Activation and Cancer
doi 10.3389/fonc.2012.00005
- 23,519 views
- 93 citations
PERSPECTIVE
Published on 19 Jan 2012
Coordinate to Guard: Crosstalk of Phosphorylation, Sumoylation, and Ubiquitylation in DNA Damage Response
doi 10.3389/fonc.2011.00061
- 4,679 views
- 5 citations
REVIEW
Published on 09 Jan 2012
The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
doi 10.3389/fonc.2011.00060
- 11,878 views
- 47 citations
REVIEW
Published on 04 Jan 2012
Skp2 is a Promising Therapeutic Target in Breast Cancer
doi 10.3389/fonc.2011.00057
- 12,270 views
- 75 citations
